This Article Full Text Full Text (PDF) Other Versions of this Article: JCM.00642-07v1 45/8/2701    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Balajee, S. A. Articles by Brandt, M. E. Search for Related Content PubMed PubMed Citation Articles by Balajee, S. A. Articles by Brandt, M. E.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2007, p. 2701-2703, Vol. 45, No. 8
0095-1137/07/$08.00+0     doi:10.1128/JCM.00642-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Nonsporulating Clinical Isolate Identified as Petromyces alliaceus (Anamorph Aspergillus alliaceus) by Morphological and Sequence-Based Methods

Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia,¹ City of Hope National Medical Center, Duarte, California,² Division of Infectious Diseases, University of Alabama at Birmingham, Alabama³

Received 22 March 2007/ Returned for modification 3 May 2007/ Accepted 22 May 2007

Concerted morphological and sequencing-based strategies revealed the identity of a nonsporulating clinical isolate as Petromyces alliaceus (anamorph Aspergillus alliaceus). This rare Aspergillus sp. was recovered as the etiological agent of invasive pulmonary aspergillosis and had reduced in vitro susceptibilities to amphotericin B and caspofungin, which correlated with clinical failure of therapy.

Published ahead of print on 30 May 2007.

This article has been cited by other articles:

• Balajee, S.A., Houbraken, J., Verweij, P.E., Hong, S-B., Yaghuchi, T., Varga, J., Samson, R.A. (2007). Aspergillus species identification in the clinical setting.. SIM 59: 39-46 [Abstract] [Full Text]